Clinically Meaningful Reduction in Dyspareunia Is Associated With Significant Improvements in Health-Related Quality of Life Among Women With Moderate to Severe Pain Associated With Endometriosis: A Pooled Analysis of Two Phase III Trials of Elagolix

Endometriosis

Achieving clinically meaningful response in endometriosis pain symptoms is associated with improvements in health-related quality of life and work productivity: Analysis of 2 phase III clinical trials

Am J Obstet Gynecol.

Pokrzywinski RM, Soliman AM, Chen J, Snabes MC, Coyne KS, Surrey ES, Taylor HS

doi: 10.1016/j.ajog.2019.11.1255.

Endometriosis

Health-Related Quality of Life Improvements in Patients With Endometriosis Treated With Elagolix

Obstet Gynecol.

Taylor HS, Soliman AM, Johns B, Pokrzywinski RM, Snabes M, Coyne KS

doi: 10.1097/AOG.0000000000003917.

Endometriosis

Impact of elagolix on work loss due to endometriosis-associated pain: estimates based on the results of two phase III clinical trials

Fertil Steril.

Pokrzywinski RM, Soliman AM, Chen J, Snabes M, Diamond MP, Surrey E, Coyne KS

doi: 10.1016/j.fertnstert.

Endometriosis

Impact of elagolix treatment on fatigue experienced by women with moderate to severe pain associated with endometriosis

Fertil Steril.

Surrey ES, Soliman AM, Agarwal SK, Snabes MC, Diamond MP

doi: 10.1016/j.fertnstert.

Endometriosis

Depressive symptoms among women with endometriosis: a systematic review and meta-analysis

Am J Obstet Gynecol.

Gambadauro P, Carli V, Hadlaczky G

doi: 10.1016/j.ajog.2018.11.123.

Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension Studies

Obstet Gynecol.

Surrey E, Taylor HS, Giudice L, Lessey BA, Abrao MS, Archer DF, Diamond MP, Johnson NP, Watts NB, Gallagher JC, Simon JA, Carr BR, Dmowski WP, Leyland N, Singh SS, Rechberger T, Agarwal SK, Duan WR, Schwefel B, Thomas JW, Peloso PM, Ng J, Soliman AM, Chwalisz K

doi: 10.1097/AOG.

Endometriosis

Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial

Fertil Steril.

Donnez J, Taylor HS, Taylor RN, Akin MD, Tatarchuk TF, Wilk K, Gotteland JP, Lecomte V, Bestel E

doi: 10.1016/j.fertnstert.

Overactive BladderUrinary Incontinence

Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health-Related Quality of Life in Patients with Overactive Bladder

doi: 10.1016/j.juro.2017.05.068.

COMMENTED

Endometriosis

Reduced pain thresholds and signs of sensitization in women with persistent pelvic pain and suspected endometriosis

Acta Obstet Gynecol Scand.

Grundström H, Gerdle B, Alehagen S, Berterö C, Arendt-Nielsen L, Kjølhede P

doi: 10.1111/aogs.13508.

Related content

Achieving clinically meaningful response in endometriosis pain symptoms is associated with improvements in health-related quality of life and work productivity: Analysis of 2 phase III clinical trials

Health-Related Quality of Life Improvements in Patients With Endometriosis Treated With Elagolix

Impact of elagolix on work loss due to endometriosis-associated pain: estimates based on the results of two phase III clinical trials

Impact of elagolix treatment on fatigue experienced by women with moderate to severe pain associated with endometriosis

Depressive symptoms among women with endometriosis: a systematic review and meta-analysis

Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension Studies

Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial

Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health-Related Quality of Life in Patients with Overactive Bladder

Reduced pain thresholds and signs of sensitization in women with persistent pelvic pain and suspected endometriosis